Hepatolenticular Degeneration - 16 Studies Found
| Completed |
: Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease : Wilson Disease : 2011-11-11 : Drug: Once a day Trientine Trientine at a dosage of ~15 mg/kg rounded upwards to the nearest 250 or 300 |
| Active, not recruiting |
: The Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment : Wilson Disease : 2016-05-03 |
| Completed |
: Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. : Wilson's Disease : 2005-09-13 : Drug: NPC-02 zinc acetate |
| Active, not recruiting |
: Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients : Wilson Disease : 2014-10-20 : Drug: WTX101 Dosage Form: 15 mg Tablets |
| Recruiting |
: sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis : Wilsons Disease : 2016-02-26 :
|
| Completed |
: A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients : Wilson's Disease : 2013-06-06 : Drug: trientine dihydrochloride Patients will take their normal prescribed dose (x1) of trientine dihydr |
| Recruiting |
: Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine : Wilson Disease : 2014-09-18 : Drug: trientine dihydrochloride A retrospective review of patients' medical records |
| Completed |
: Study of Zinc for Wilson Disease : Wilson Disease : 1999-10-18 : Drug: zinc acetate |
| Completed |
: Study of Tetrathiomolybdate in Patients With Wilson Disease : Wilson Disease : 1999-10-18 :
|
| Completed |
: Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis : Wilson's Disease : 2011-06-20 : Genetic: allogeneic mesenchymal stem cell transplantation 1.000.000(one million) cells/kg, IV (1/2 of do |